These novel therapies , Retatrutide, represent a groundbreaking advancement in treating type 2 diabetes and conceivably related disorders. These drugs are classified as GLP-1 hormone agonists , meaning https://adrianaleil193736.howeweb.com/41993109/semaglutide-a-deep-exploration-into-incretin-agents